JPWO2020161623A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020161623A5
JPWO2020161623A5 JP2021545808A JP2021545808A JPWO2020161623A5 JP WO2020161623 A5 JPWO2020161623 A5 JP WO2020161623A5 JP 2021545808 A JP2021545808 A JP 2021545808A JP 2021545808 A JP2021545808 A JP 2021545808A JP WO2020161623 A5 JPWO2020161623 A5 JP WO2020161623A5
Authority
JP
Japan
Prior art keywords
pyridin
sulfamoyl
trifluoromethyl
amino
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021545808A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022519301A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/050884 external-priority patent/WO2020161623A1/en
Publication of JP2022519301A publication Critical patent/JP2022519301A/ja
Publication of JPWO2020161623A5 publication Critical patent/JPWO2020161623A5/ja
Withdrawn legal-status Critical Current

Links

JP2021545808A 2019-02-06 2020-02-04 N-(ピリジン-2-イル)ピリジン-スルホンアミド誘導体及び疾患の処置におけるそれらの使用 Withdrawn JP2022519301A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962801717P 2019-02-06 2019-02-06
US62/801,717 2019-02-06
PCT/IB2020/050884 WO2020161623A1 (en) 2019-02-06 2020-02-04 N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of disease

Publications (2)

Publication Number Publication Date
JP2022519301A JP2022519301A (ja) 2022-03-22
JPWO2020161623A5 true JPWO2020161623A5 (enExample) 2023-02-13

Family

ID=69528901

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021545808A Withdrawn JP2022519301A (ja) 2019-02-06 2020-02-04 N-(ピリジン-2-イル)ピリジン-スルホンアミド誘導体及び疾患の処置におけるそれらの使用

Country Status (5)

Country Link
US (1) US20220127247A1 (enExample)
EP (1) EP3921313A1 (enExample)
JP (1) JP2022519301A (enExample)
CN (1) CN113423702A (enExample)
WO (1) WO2020161623A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3752510T (lt) 2018-02-15 2023-04-11 Vertex Pharmaceuticals Incorporated Makrocikliniai junginiai kaip cistinės fibrozės transmembraninio laidumo reguliatoriaus moduliatoriai, jų farmacinės kompozicijos, jų panaudojimas cistinės fibrozės gydymui ir jų gamybos būdas
UY38630A (es) 2019-04-03 2020-10-30 Vertex Pharma Agentes moduladores del regulador de la conductancia transmembrana de la fibrosis quística
WO2021030552A1 (en) 2019-08-14 2021-02-18 Vertex Pharmaceuticals Incorporated Crystalline forms of cftr modulators
EP4013741B1 (en) 2019-08-14 2024-04-17 Vertex Pharmaceuticals Incorporated Process of making cftr modulators
TWI867024B (zh) 2019-08-14 2024-12-21 美商維泰克斯製藥公司 囊腫纖維化跨膜傳導調節蛋白之調節劑
KR20230118123A (ko) 2020-12-10 2023-08-10 버텍스 파마슈티칼스 인코포레이티드 낭성 섬유증 치료 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0301654D0 (sv) * 2003-06-05 2003-06-05 Astrazeneca Ab Novel compounds
EP3116870A1 (en) * 2014-03-13 2017-01-18 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for increasing cftr activity
EP3303294A1 (en) * 2015-06-02 2018-04-11 Abbvie S.a.r.l. Substituted pyridines and method of use
TW201811766A (zh) * 2016-08-29 2018-04-01 瑞士商諾華公司 N-(吡啶-2-基)吡啶-磺醯胺衍生物及其用於疾病治療之用途

Similar Documents

Publication Publication Date Title
JP2004506718A5 (enExample)
JP2023027269A5 (enExample)
JP3581713B2 (ja) ホスホジエステラーゼ阻害剤としての三置換フェニル誘導体
US10968172B2 (en) USP30 inhibitors
JP2012506446A5 (enExample)
RU2469032C2 (ru) Производные 2-(пиперидин-4-ил)-4-фенокси- или фениламинопиримидина в качестве ненуклеозидных ингибиторов обратной транскриптазы
JP4946861B2 (ja) ヒストンデアセチラーゼ(hdac)の阻害活性を有するヒドロキシアミド化合物
JP2024532518A (ja) Glp1rアゴニストとしての新規アリールエーテル置換複素環式化合物
JP2004504301A5 (enExample)
RU2315041C2 (ru) Производные 2,6-хинолинила и 2,6-нафтила, фармацевтические композиции на их основе, их применение в качестве ингибиторов vla-4 и промежуточные соединения
IL274816B2 (en) Sulfone pyridine alkyl amide-substituted heteroaryl compounds
CA2418868A1 (en) 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
JP2014532640A5 (enExample)
JP2004521095A5 (enExample)
JP2010538076A5 (enExample)
JP2007502264A5 (enExample)
JP2005522448A5 (enExample)
JP2001505586A (ja) Pde iv阻害剤として有用なトリアリールエタン
RU2013150811A (ru) Ингибиторы идо
RU2007128949A (ru) Конденсированные бициклические карбоксамидные производные, используемые в качестве ингибиторов схсr2 для лечения воспалений
JP2010540462A5 (enExample)
JP2008512470A5 (enExample)
JP2008516968A5 (enExample)
JPWO2020161623A5 (enExample)
JP2004504400A5 (enExample)